Genetic polymorphisms of cytochrome P450c17α (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risk

Gynecological Endocrinology

Volumn 23, Issue 1, 2007, Pages 29-33

  De Carvalho, Cristina Valleta ^a   Nogueira de Souza, Naiara Correa ^a   Costa, Ana Maria Massad ^a   Baracat, Edmund Chada ^a   Girão, Manoel J B C ^a   D'amora, Paulo ^a   Schor, Eduardo ^a   Silva, Ismael D C G Da ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

CYP17; Endometriosis; Polymorphism; Progesterone receptor

Indexed keywords

CYTOCHROME P450C17; GENOMIC DNA; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CHEEK; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; DYSPAREUNIA; ENDOMETRIOSIS; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PELVIS PAIN SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; REPRODUCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TIME SERIES ANALYSIS; ULTRASOUND; UTERUS SURGERY;

ADULT; CASE-CONTROL STUDIES; DNA; DNA PRIMERS; ENDOMETRIOSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, PROGESTERONE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STEROID 17-ALPHA-HYDROXYLASE;

EID: 33847044393     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590601024707     Document Type: Article

References (29)

1. Mitrunen K, Hirvonen A. Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 2003;544:9-41.
2. Huber JC, Schneeberger C, Tempfer CB. Genetic modeling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas 2002;42:1-12.
3. Carey AH, Waterworth D, Patel K, White D, Little J, Novelli P, Franks S, Williamson R. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet 1994;3:1873-1876.
4. Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999;59:1015-1020.
5. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK, Henderson BE. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997;57:1063-1065.
6. Feigelson HS, McKean-Cowdin R, Coetzee GA, Stram DO, Kolonel LN, Henderson BE. Building a multigenic model of breast cancer susceptibility: CYP17 and HSD17B1 are two important candidates. Cancer Res 2001;61:785-789.
7. Huang CS, Chern HD, Chang KJ, Cheng CW, Hsu SM, Shen CY. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility. Cancer Res 1999;59:4870-4875.
8. Miyoshi Y, Iwao K, Ikeda N, Egawa C, Noguchi S. Genetic polymorphism in CYP17 and breast cancer risk in Japanese women. Eur J Cancer 2000;36:2375-2379.
9. Ehrlich CE, Young PC, Stehman FB, Sutton GP, Alford WM. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 1988;158:796-807.
10. Punyadeera C, Verbost P, Groothuis P. Oestrogen and progestin responses in human endometrium. J Steroid Biochem Mol Biol 2003;84:393-410.
11. McKenna NJ, Kieback DG, Carney DN, Fanning M, McLinden J, Headon DR. A germline TaqI restriction fragment length polymorphism in the progesterone receptor gene in ovarian carcinoma. Br J Cancer 1995;71:451-455.
12. Agoulnik IU, Tong XW, Fischer DC, Korner K, Atkinson NE, Edwards DP, Headon DR, Weigel NL, Kieback DG. A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. J Clin Endocrinol Metab 2004;89:6340-6347.
13. Wieser F, Schneeberger C, Tong D, Tempfer C, Huber JC, Wenzl R. PROGINS receptor gene polymorphism is associated with endometriosis. Fertil Steril 2002;77:309-312.
14. Wang-Gohrke S, Chang-Claude J, Becher H, Kieback DG, Runnebaum IB. Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Res 2000;60:2348-2350.
15. Donaldson CJ, Crapanzano JP, Watson JC, Levine EA, Batzer MA. PROGINS Alu insertion and human genomic diversity. Mutat Res 2002;501:137-141.
16. Chiang CL. Statistical methods of analysis. Hackensack, NJ: World Scientific; 2003.
17. Higgins JJ. Introduction to modern nonparametric statistics. Lobethal, SA, Australia: Thomson-Brooks/Cole; 2004.
18. Lattuada D, Somigliana E, Vigano P, Candiani M, Pardi G, DiBlasio AM. Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clin Endocrinol (Oxf) 2004;61:190-194.
19. Treloar SA, Zhao ZZ, Armitage T, Duffy DL, Wicks J, O'Connor DT, Martin NG, Montgomery GW. Association between polymorphisms in the progesterone receptor gene and endometriosis. Mol Hum Reprod 2005;11:641-647.
20. Pijnenborg JMA, Romano A, Dam-de Veen GC, Dunselman GAJ, Fischer D-C, Groothuis PG, Kieback DG. Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma. J Pathol 2005;205:597-605.
21. DeVivo I, Hankinson SE, Colditz GA, Hunter DJA. A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Res 2003;63:5236-5238.
22. Ioannidis JPA, Trikalinos TA, Ntzani EE, Contopoulos-Ioannidis DG. Genetic associations in large versus small studies: an empirical assessment. Lancet 2003;361:567-571.
23. Kurz C, Tempfer CB, Boecskoer S, Unfried G, Nagele F, Hefler LA. The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Invest 2001;8:295-298.
24. Huber A, Keck CC, Hefler LA, Schneeberger C, Huber JC, Bentz EK, Tempfer CB. Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions. Obstet Gynecol 2005;106:1025-1031.
25. Guo SW. Association of endometriosis risk and genetic polymorphisms involving sex steroid biosynthesis and their receptors: a meta-analysis. Gynecol Obstet Invest 2005;61:90-105.
26. Asghar T, Yoshida S, Nakago S, Morizane M, Ohara N, Motoyama S, Kennedy S, Barlow D, Maruo T. Lack of association between endometriosis and the CYP17 MspA1 polymorphism in UK and Japanese populations. Gynecol Endocrinol 2005;20:59-63.
27. Kado N, Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Tsukamoto K, Hasegawa G, Nakamura N, Yoshikawa T, et al. Association of the CYP17 gene and CYP19 gene polymorphisms with risk of endometriosis in Japanese women. Hum Reprod 2002;17:897-902.
28. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH. Estrogen receptor α dinucleotide repeat and cytochrome P450c17α gene polymorphisms are associated with susceptibility to endometriosis. Fertil Steril 2005;83:567-572.
29. Thomas DC, Witte JS. Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002;11:505-512.